P. Lenting

发表

Increased metastatic potential of tumor cells in von Willebrand factor‐deficient mice

D Meyer, D. Baruch, P. Lenting, 2006, Journal of thrombosis and haemostasis : JTH.

The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein*

J. V. van Mourik, A. V. van Zonneveld, H. Pannekoek, 1999, The Journal of Biological Chemistry.

C. Gahmberg, J. Zwaginga, E. Westein, 2004 .

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Cohort

S. Porouchani, J. Dallongeville, C. Casari, 2022, Circulation.

Depletion of CD4+/CD25high regulatory T cells may enhance or uncover factor VIII‐specific T‐cell responses in healthy individuals

P. Lenting, T. Mutis, C. Kamaté, 2007, Journal of thrombosis and haemostasis : JTH.

P-selectin glycoprotein ligand (PSGL)-1 and β 2-integrins cooperate in adhesion of leukocytes to von Willebrand factor

C. Gahmberg, O. Christophe, C. Denis, 2006 .

Interaction of β2‐glycoprotein I with members of the low density lipoprotein receptor family

R. Romijn, R. Derksen, R. Urbanus, 2006, Journal of thrombosis and haemostasis : JTH.

Clearance mechanisms of von Willebrand factor and factor VIII

P. Lenting, C. Denis, C. V. van Schooten, 2007, Journal of thrombosis and haemostasis : JTH.

Cleavage at Arginine 145 in Human Blood Coagulation Factor IX Converts the Zymogen into a Factor VIII Binding Enzyme (*)

J. V. van Mourik, K. Mertens, P. Lenting, 1995, The Journal of Biological Chemistry.

The Sequence GluLys of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX (*)

P. Lenting, J. V. van Mourik, K. Mertens, 1996, The Journal of Biological Chemistry.

Blood Coagulation Factor IX Residues Glu78 and Arg94 Provide a Link between Both Epidermal Growth Factor-like Domains That Is Crucial in the Interaction with Factor VIII Light Chain*

O. Christophe, P. Lenting, G. Brownlee, 1998, The Journal of Biological Chemistry.

von Willebrand factor: the old, the new and the unknown

C. Casari, O. Christophe, P. Lenting, 2012, Journal of thrombosis and haemostasis : JTH.

Towards novel treatment options in von Willebrand disease

C. Casari, P. Lenting, Claire Kizlik‐Manson, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Platelet von Willebrand factor: sweet resistance.

C. Denis, P. Lenting, 2013, Blood.

Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia.

C. Casari, A. Kauskot, P. D. de Groot, 2013, Blood.

Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions

J. Emsley, G. Silverman, T. Foster, 2006, The FEBS journal.

Antithrombotic potential of a single‐domain antibody enhancing the activated protein C‐cofactor activity of protein S

F. Adam, O. Christophe, C. Denis, 2022, Journal of thrombosis and haemostasis : JTH.

Of von Willebrand factor and platelets

M. Bryckaert, J. Rosa, P. Lenting, 2014, Cellular and Molecular Life Sciences.

Cysteine‐mutations in von Willebrand factor associated with increased clearance

P. Lenting, C. Denis, R. Bertina, 2005, Journal of thrombosis and haemostasis : JTH.

Factor VIII-Factor IX Interactions: Molecular Sites Involved in Enzyme-Cofactor Complex Assembly

P. Lenting, J. Kolkman, P. Celie, 1999, Thrombosis and Haemostasis.

Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.

G. Lemesle, F. Mouquet, J. Dallongeville, 2016, The New England journal of medicine.

Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi

S. Diamond, C. Denis, C. Ali, 2017, Circulation.

Shear stress‐independent binding of von Willebrand factor‐type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance

C. Casari, P. Legendre, O. Christophe, 2015, Journal of thrombosis and haemostasis : JTH.

Factor VIII and von Willebrand factor – too sweet for their own good

O. Christophe, P. Lenting, C. Denis, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis

E. Belle, S. Susen, A. Rauch, 2015, Journal of thrombosis and haemostasis : JTH.

ADAMTS‐13: double trouble for von Willebrand factor

P. Lenting, G. Rastegarlari, 2010, Journal of thrombosis and haemostasis : JTH.

von Willebrand factor clearance does not involve proteolysis by ADAMTS‐13

P. Legendre, O. Christophe, C. Denis, 2010, Journal of thrombosis and haemostasis : JTH.

Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.

P. Legendre, P. D. de Groot, O. Christophe, 2010, Blood.

Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization

R. Neviere, C. Casari, O. Christophe, 2022, Research and practice in thrombosis and haemostasis.

von Willebrand factor propeptide and the occurrence of a first ischemic stroke

P. D. de Groot, P. Lenting, F. Leebeek, 2010, Journal of thrombosis and haemostasis : JTH.

Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients

T. Renné, B. Bouma, A. Squizzato, 2011, Journal of thrombosis and haemostasis : JTH.

Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID‐19: Response from Original Authors Susen, et al.

S. Susen, A. Rauch, P. Lenting, 2020, Journal of Thrombosis and Haemostasis.

von Willebrand Factor and Management of Heart Valve Disease

C. Casari, E. Belle, S. Susen, 2019 .

Antithrombin lowering in hemophilia: a closer look at fitusiran

B. Nolan, G. Young, S. Croteau, 2023, Research and practice in thrombosis and haemostasis.

How to keep the factor VIII/von Willebrand factor complex in the circulation

C. Denis, P. Lenting, 2021, Haematologica.

The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission

P. D. de Groot, P. Lenting, R. Fijnheer, 2009, Journal of thrombosis and haemostasis : JTH.

Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort study

A. Ganser, P. Lenting, A. Tiede, 2008, Journal of thrombosis and haemostasis : JTH.

von Willebrand factor activation, granzyme‐B and thrombocytopenia in meningococcal disease

L. Joosten, P. D. de Groot, P. Lenting, 2010, Journal of thrombosis and haemostasis : JTH.

Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome

A. Franx, P. D. de Groot, P. Lenting, 2006, Journal of thrombosis and haemostasis : JTH.

B. M. V. D. Berg, Pannekoek, P. Lenting, 2011 .

Platelet von Willebrand factor: sweet resistance.

C. Denis, P. Lenting, 2013, Blood.

Clearance of von Willebrand factor

C. Casari, O. Christophe, P. Lenting, 2013, Journal of thrombosis and haemostasis : JTH.